A study to investigate expression of specific Proteins in Bladder Cancer
Not Applicable
- Conditions
- Health Condition 1: C67- Malignant neoplasm of bladder
- Registration Number
- CTRI/2024/05/067297
- Lead Sponsor
- Maulana Azad Medicl College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who have undergone cystectomy for urinary bladder carcinoma.
Exclusion Criteria
Patients who have received radiotherapy and chemotherapy will be excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expression of ALDH1A1 and NANOG in urinary bladder carcinoma and its association between immunohistochemical expression of ALDH1A1 and NANOG and clinicopathological parameters such as tumor size, location, grade, stage, muscle invasion, metastasis, lympho-vascular invasion and perineural invasionTimepoint: Baseline
- Secondary Outcome Measures
Name Time Method Association between immunohistochemical expression of ALDH1A1 & NANOG & clinicopathological parameters such as tumor size location grade stage muscle invasion metastasis lymphovascular invasion & perineural invasionTimepoint: Baseline